Silicon Valley/Hamburg – The Eqwal Group, a global player in the prosthetics and orthotics market, has acquired all shares in Preisler Group GmbH through its German subsidiary, Ortho Dev Deutschland GmbH. The Preisler Group brings together several companies specialising in technical orthopaedics, rehabilitation, physiotherapy and occupational therapy, thereby covering a broad spectrum of orthopaedic care. With this acquisition, Eqwal is continuing to expand its activities in the German market for orthopaedic care and is strengthening its presence across various areas of patient care.
A CMS team led by Dr Eckart Gottschalk provided comprehensive legal advice to Ortho Dev Deutschland GmbH in connection with the acquisition. The advice covered, in particular, legal due diligence and support with the transaction documentation. The financial details of the transaction are being treated as confidential.
Ortho Dev Deutschland GmbH is part of the Eqwal Group, an international company specialising in the development, manufacture and distribution of prostheses and orthoses. With a global network of partner companies and subsidiaries, Eqwal develops and markets solutions for people with mobility impairments. In Germany, the Group is continuously expanding its activities in the field of orthopaedic care.
Preisler Group GmbH holds all the shares in Optimus – Zentrum für technische Orthopädie GmbH, PhysioPlus GmbH, Pro-Walk Rehabilitationshilfen und Sanitätsbedarf Gesellschaft mbH and Pro Walk Innovation GmbH. The group develops, manufactures and distributes orthopaedic and rehabilitation products and provides technical orthopaedic services as well as personalised patient care. It also operates physiotherapy and occupational therapy centres.
This transaction marks the third acquisition by the Eqwal Group in Germany since November 2025 for which CMS has provided legal advice. Previously, CMS had already advised the group on the Acquisition of the Schindler Orthopaedics Group as well as the Kurtze Orthopaedic Technology Ltd advise.
